| A STING-activating nanovaccine for cancer immunotherapy M Luo, H Wang, Z Wang, H Cai, Z Lu, Y Li, M Du, G Huang, C Wang, ... Nature nanotechnology 12 (7), 648-654, 2017 | 731 | 2017 |
| Gold nanoclusters and graphene nanocomposites for drug delivery and imaging of cancer cells C Wang, J Li, C Amatore, Y Chen, H Jiang, XM Wang Angewandte Chemie 123 (49), 11848-11852, 2011 | 339 | 2011 |
| Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor L Ma, T Dichwalkar, JYH Chang, B Cossette, D Garafola, AQ Zhang, ... Science 365 (6449), 162-168, 2019 | 321 | 2019 |
| Optical molecular imaging for tumor detection and image-guided surgery C Wang, Z Wang, T Zhao, Y Li, G Huang, BD Sumer, J Gao Biomaterials 157, 62-75, 2018 | 210 | 2018 |
| Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes C Wang, T Zhao, Y Li, G Huang, MA White, J Gao Advanced drug delivery reviews 113, 87-96, 2017 | 153 | 2017 |
| Molecular basis of cooperativity in pH-triggered supramolecular self-assembly Y Li, T Zhao, C Wang, Z Lin, G Huang, BD Sumer, J Gao Nature communications 7 (1), 13214, 2016 | 145 | 2016 |
| Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan C Wang, H Niederstrasser, PM Douglas, R Lin, J Jaramillo, Y Li, ... Nature communications 8 (1), 2270, 2017 | 138 | 2017 |
| Digitization of Endocytic pH by Hybrid Ultra-pH Sensitive Nanoprobes at Single Organelle Resolution Y Wang, C Wang, Y Li, G Huang, T Zhao, X Ma, Z Wang, BD Sumer, ... Advanced Materials (Deerfield Beach, Fla.) 29 (1), 2017 | 78 | 2017 |
| A nanobuffer reporter library for fine-scale imaging and perturbation of endocytic organelles. C Wang, Y Wang, Y Li, B Bodemann, T Zhao, X Ma, G Huang, Z Hu, ... Nature communications 6, 8524-8524, 2015 | 78 | 2015 |
| Enhancement of peptide vaccine immunogenicity by increasing lymphatic drainage and boosting serum stability KD Moynihan, RL Holden, NK Mehta, C Wang, MR Karver, J Dinter, ... Cancer immunology research 6 (9), 1025-1038, 2018 | 62 | 2018 |
| Exploiting albumin as a mucosal vaccine chaperone for robust generation of lung-resident memory T cells DJI Kavya Rakhra, Wuhbet Abraham, Chensu Wang, Kelly D. Moynihan, Na Li ... Science Immunology 6 (57), eabd8003, 2021 | 55 | 2021 |
| Regulation of hematopoiesis and methionine homeostasis by mTORC1 inhibitor NPRL2 PA Dutchak, S Laxman, SJ Estill, C Wang, Y Wang, Y Wang, GB Bulut, ... Cell reports 12 (3), 371-379, 2015 | 48 | 2015 |
| PET imaging of occult tumours by temporal integration of tumour-acidosis signals from pH-sensitive 64Cu-labelled polymers G Huang, T Zhao, C Wang, K Nham, Y Xiong, X Gao, Y Wang, G Hao, ... Nature Biomedical Engineering, 1, 2019 | 46 | 2019 |
| Inhibition of Ral GTPases using a stapled peptide approach JC Thomas, JM Cooper, NS Clayton, C Wang, MA White, C Abell, D Owen, ... Journal of Biological Chemistry 291 (35), 18310-18325, 2016 | 26 | 2016 |
| Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade C Wang, A Cui, M Bukenya, A Aung, D Pradhan, CA Whittaker, Y Agarwal, ... Cell reports 37 (8), 2021 | 24 | 2021 |
| Murine CD8 T‐cell functional avidity is stable in vivo but not in vitro: independence from homologous prime/boost time interval and antigen density CB Gilfillan, C Wang, MO Mohsen, N Rufer, M Hebeisen, M Allard, ... European journal of immunology 50 (4), 505-514, 2020 | 7 | 2020 |
| Research progress of graphene-based materials in the application to biomedicine H Jiang, XM Wang, CS Wang Yao xue xue bao= Acta Pharmaceutica Sinica 47 (3), 291-298, 2012 | 2 | 2012 |
| Combination immunotherapy of αPD-1 and extended half-life IL-2 clears established GL261 gliomas in an MHC class I independent fashion ZP Tritz, K Ayasoufi, C Malo, B Himes, R Khadka, L Yokanovich, ... The Journal of Immunology 204 (1_Supplement), 169.15-169.15, 2020 | 1 | 2020 |
| 564 Single-cell transcriptomic analysis of immune compartments following combination immunotherapy treatment in poorly immunogenic tumors A Cui, K Moynihan, S Li, C Wang, J Southard, N Hacohen, D Irvine Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A593-A593, 2021 | | 2021 |
| COMBINATION IMMUNOTHERAPY DOSING REGIMEN FOR IMMUNE CHECKPOINT BLOCKADE C WANG, DJ IRVINE, KD WITTRUP US Patent App. No. 16/692,892, 2019 | | 2019 |
